Evidence map›Paper›PMID 37012048›Full record

ArticleLife science alliance2023

Dynamic changes of enhancer and super enhancer landscape in degenerated nucleus pulposus cells.

Guowang Li, Yuxiang Kang, Xiangling Feng, Guohua Wang, Yue Yuan, Zhenhua Li, Lilong Du, Baoshan Xu

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Guowang LiDepartment of Minimally Invasive Spine Surgery, Tianjin Hospital, Tianjin, China.
Yuxiang KangGraduate School of Tianjin Medical University, Tianjin, China.ORCID https://orcid.org/0000-0002-2706-2901
Xiangling FengGraduate School of Tianjin Medical University, Tianjin, China.ORCID https://orcid.org/0000-0003-4668-6709
Guohua WangGraduate School of Tianjin Medical University, Tianjin, China.
Yue YuanGraduate School of Tianjin Medical University, Tianjin, China.
Zhenhua LiDepartment of Minimally Invasive Spine Surgery, Tianjin Hospital, Tianjin, China.
Lilong DuDepartment of Minimally Invasive Spine Surgery, Tianjin Hospital, Tianjin, China.
Baoshan XuDepartment of Minimally Invasive Spine Surgery, Tianjin Hospital, Tianjin, China baoshanxu99@tmu.edu.cn.ORCID https://orcid.org/0000-0002-4407-8745
Tianjin Hospital · CNTianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory cascade and extracellular matrix remodeling have been identified as pivotal pathological factors in the progression of intervertebral disc degeneration (IDD), but the mechanisms underlying the aberrant activation of transcription during nucleus pulposus (NP) cell degeneration remain elusive. Super-enhancers (SEs) are large clusters of adjacent lone enhancers, which control expression modes of cellular fate and pathogenic genes. Here, we showed that SEs underwent tremendous remodeling during NP cell degeneration and that SE-related transcripts were most abundant in inflammatory cascade and extracellular matrix remodeling processes. Inhibition of cyclin-dependent kinase 7, a transcriptional kinase-mediated transcriptional initiation in trans-acting SE complex, constricted the transcription of inflammatory cascades, and extracellular matrix remodeling-related genes such as

Indexed as

Intervertebral Disc DegenerationNucleus PulposusAnimalsCyclin-Dependent KinasesRatsCyclin-Dependent Kinases

Identifiers

PMID37012048
PMCPMC10070812
OpenAlexW4362521277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.